Raymond U Osarogiagbon MD

Physician

6029 Walnut Grove RoadSte 305Memphis, TN 38120
Phone+1 901-752-6131
Fax+1 901-751-6170

Dr. Osarogiagbon is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Osarogiagbon's full profile Already have an account?

Education & Training

University of MinnesotaFellowship, Hematology and Medical Oncology, 1995 - 1998
Texas Tech University (Amarillo)Residency, Internal Medicine, 1992 - 1995
University of IbadanClass of 1988

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MS State Medical License 2005 - 2027
TN State Medical License 2004 - 2027
MN State Medical License 1995 - 2014
TX State Medical License 2000 - 2014
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016
CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2013-2014, 2016
Memphis Magazine: Top Doctors Castle Connolly, 2008-2014

Clinical Trials

Building a Multidisciplinary Bridge Across the Quality Chasm in Thoracic Oncology Start of enrollment: 2014 Oct 09
COMPLETED
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Jul 08
COMPLETED
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches
COMPLETED
PHASE2

Publications & Presentations

PubMed

Variability Among Radiologists in Interpreting Low-Dose CT Lung Cancer Screens.
Paul F Pinsky, Ella Kazerooni, Gerard Silvestri, Raymond U Osarogiagbon, Farhood Farjah
Journal of the American College of Radiology. 2026-08-10
Rates of Systemic Treatment for Metastatic Non-Small Cell Lung Cancer Among Older Adults.
Adam H Fox, Ralph C Ward, Mariam Alexander, Raymond U Osarogiagbon, Robert A Smith
JAMA Oncology. 2026-07-01
1 citations
PROSPECT-LUNG: A National Clinical Trials Network Trial Advancing Pragmatic Innovation in Cancer Clinical Trials.
Allison Booth, Shauna Hillman, Kristina Laumann, Ying-Qi Zhao, Michael LeBlanc
Journal of Thoracic Oncology. 2026-07-01

Lectures

Prospective comparative effectiveness trial of multidisciplinary lung cancer (LC) care.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Biomarker-Guided Adjuvant Treatment Supports Real-World Survival in Early NSCLCJune 10th, 2025
Lung Cancer Screening with LD Lung – Missed Opportunities for Early Lung Cancer DetectionSeptember 16th, 2024
Researchers: Lung Nodule Programs Can Catch Cancer EarlyMarch 10th, 2023